To further confirm that inhibition of AKT/mTOR and MEK/ERK contribute to esophageal cancer cell migration, we applied the ERK inhibitor U0126 and the AKT inhibitor LY294002 to Eca109 cells and measure their effect using wound healing assay. This evidence concerns the gene MTOR and esophageal cancer.